Trichomonas, Candida, and Gardnerella in cervical smears of Iranian women for cancer screening

North American Journal of Medical Sciences

Volumn 6, Issue 1, 2014, Pages 25-29

  Kalantari, Narges ^a   Ghaffari, Salman ^b   Bayani, Masomeh ^c  

^a Cellular and Molecular Biology Research Center   (Iran)

^b Department of Parasitology Mycology ^*  (Iran)

^c BABOL UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Candida sp; Gardnerella vaginalis; Pap smear; T. vaginalis

Indexed keywords

ADULT; AGE; ARTICLE; CANCER SCREENING; CANDIDA; CONTRACEPTION; CONTROLLED STUDY; FEMALE; GARDNERELLA VAGINALIS; HUMAN; HUMAN TISSUE; IRAN; MAJOR CLINICAL STUDY; MIDDLE AGED; MIXED INFECTION; PAPANICOLAOU TEST; PREVALENCE; RETROSPECTIVE STUDY; RISK FACTOR; TRICHOMONAS VAGINALIS; UTERINE CERVIX CYTOLOGY; VAGINITIS;

EID: 84893049158     PISSN: 22501541     EISSN: 19472714     Source Type: Journal    
DOI: 10.4103/1947-2714.125861     Document Type: Article

References (32)

1. Boone JD, Erickson BK, Huh WK. New insights into cervical cancer screening. J Gynecol Oncol 2012;23:282-7.
2. Castellsague X, Bosch FX, Munoz N. Environmental co-factors in HPV carcinogenesis. Virus Res 2002;89:191-9.
3. Hawes SE, Kiviat NB. Are genital infections and infl ammation cofactors in the pathogenesis of invasive cervical cancer? J Natl Cancer Inst 2002;94:1592-3.
4. Guijon F, Paraskevas M, Rand F, Heywood E, Brunham R, McNicol P. Vaginal microbial flora as a cofactor in the pathogenesis of uterine cervical intraepithelial neoplasia. Int J Gynecol Obstet 1992;37:185-91.
5. Wang PD, Lin RS. Epidemiologic differences between candidial and trichomonal infections as detected in cytologic smears in Taiwan. Public Health 1995;109:443-50.
6. Murta EF, Silva AO, Silva EA, Adad SJ. Frequency of infectious agents for vaginitis in non-and hysterectomized women. Arch Gynecol Obstet 2005;273:152-6.
7. Adad SJ, de Lima RV, Sawan ZT, Silva ML, de Souza MA, Saldanha JC, et al. Frequency of Trichomonas vaginalis, Candida sp and Gardnerella vaginalis in cervical-vaginal smears in four different decades. São Paulo Med J 2001;119:200-5.
8. Lessa PR, Ribeiro SG, Lima DJ, Nicolau AI, Damasceno AK, Pinheiro AK. Presence of high-grade intraepithelial lesions among women deprived of their liberty: A documental study. Rev Lat Am Enfermagem 2012;20:354-61.
9. Og A, Oe O, To A. Sensitivity of a papanicolaou smear in the diagnosis of candida albicans infection of the cervix. N Am J Med Sci 2010;2:97-9.
10. Mahdavi Omran S, Rahmani Z. Frequency and etiology of vulvovaginal candidiasis in women referred to a gynecological center in Babol, lran. Int J Fertil Steril 2009;3:74-7.
11. Klufi OCA, Amoa AB, Delamare O, Hombhanje M, Kariwiga G, Igo J. Prevalence of vaginal infections with bacterial vaginosis, Trichomonas vaginalis and Candida albicans among pregnant women at the Port Moresby General Hospital Antenatal Clinic. P NG Med J 1995;38:163-71.
12. Roeters AM, Boon ME, van Haaften M, Vernooij F, Bontekoe TR, Heintz AP. Inflammatory events as detected in cervical smears and squamous intraepithelial lesions. Diagn Cytopathol 2010;38:85-93.
13. Omoregie R, Egbe CA, Igbarumah IO, Ogefere H, Okorie E. Prevalence and etiologic agents of female reproductive tract infection among in-patients and out-patients of a tertiary hospital in Benin city, Nigeria. N Am J Med Sci 2010;2:473-7.
14. Mehmetoglu HC, Sadikoglu G, Ozcakir A, Bilgel N. Pap smear screening in the primary health care setting: A study from Turkey. N Am J Med Sci 2010;2:467-72.
15. Shobeiri F, Nazari M. A prospective study of genital infections in Hamedan, Iran. Southeast Asian J Trop Med Public Health 2006;3:174-7.
16. Boon ME, van Ravenswaay Claasen HH, Kok LP. Urbanization and baseline prevalence of genital infections including Candida, Trichomonas, and human papillomavirus and of a disturbed vaginal ecology as established in the Dutch Cervical Screening Program. Am J Obstet Gynecol 2002;187:365-9.
17. Matini M, Rezaie S, Mohebali M, Maghsood A, Rabiee S, Fallah M, et al. Prevalence of Trichomonas vaginalis Infection in Hamadan City, Western Iran. Iran J Parasitol 2012;7:67-72.
18. Bakhtiari A, Hajian-Tilaki K, Pasha H. Genital infection by Trichomonas vaginalis in women referring to Babol health centers: Prevalence and risk factors. Iran Red Crescent Med J 2008;10:16-21.
19. Calechale A, Karimi I. The prevalence of Trichomonas vaginalis infection among patients that presented to hospitals in the Kermanshah district of Iran in 2006 and 2007. Turk J Med Sci 2010;40:971-5.
20. Gillet E, Meys JF, Verstraelen H, Verhelst R, De Sutter P, Temmerman M, et al. Association between bacterial vaginosis and cervical intraepithelial neoplasia: Systematic review and meta-analysis. Plos One 2012;7:e45201.
21. Sönmez Tamer G, Keçeli Ozcan S, Yücesoy G, Gacar G. The relation between trichomoniasis and contraceptive methods. Türkiye Parazitol Derg 2009;33:266-9.
22. Soper DE, Shoupe D, Shangold GA, Shangold MM, Gutmann J, Mercer L. Prevention of vaginal trichomoniasis by compliant use of the female condom. Sex Transm Dis 1993;20:137-9.
23. Smart S, Singal A, Mindel A. Social and sexual risk factors for bacterial vaginosis. Sex Trans Infect 2004;80:58-62.
24. Hodoglugil NN, Aslan D, Bertan M. Intrauterine device use and some issues related to sexually transmitted disease screening and occurrence. Contraception 2000;61:359-64.
25. Ceruti M, Canestrelli M, Condemi V, Piantelli G, De Paolis P, Amone F, et al. Methods of contraception and rates of genital infections. Clin Exp Obstet Gynecol 1994;21:119-23.
26. Guzel AB, Ilkit M, Akar T, Burgut R, Demir SC. Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identifi cation of vaginal yeast species. Med Mycol 2011;49:16-25.
27. Tibaldi C, Cappello N, Latino MA, Masuelli G, Marini S, Benedetto C. Vaginal and endocervical microorganisms in symptomatic and asymptomatic non-pregnant females: Risk factors and rates of occurrence. Clin Microbiol Infect 2009;15:670-9.
28. Jones FR, Miller G, Gadea N, Meza R, Leon S, Perez J, et al. Collaborative HIV/STI Prevention Trial Group. Prevalence of bacterial vaginosis among young women in low-income populations of coastal Peru. Int J STD AIDS 2007;18:188-92.
29. Mendoza-Gonzalez A, Sanchez-Vega J, Sanchez-Peon I, Ruiz-Sanchez D, Tay-Zavala J. Frequency of Gardnerella vaginalis vaginosis and its association with other pathogens causing genital infections in the female. Ginecol obstet Mex 2001;69:272-6.
30. Dunne RL, Dunnl LA, Upcroft P, O'Donoghue PJ, Upcroft JA. Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis. Cell Res 2003;13:239-49.
31. Vanden Bossche H, Dromer F, Improvisi I, Lozano-Chiu M, Rex JH, Sanglard D. Antifungal drug resistance in pathogenic fungi. Med Mycol 1998;36:119-28.
32. McLean NW, McGroarty JA. Growth inhibition of metronidazole-susceptible and metronidazole-resistant strains of Gardnerella vaginalis by Lactobacilli in vitro. Appl Environ Microbiol 1996;62:1089-92.